<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="medium, provided the original work is properly cited. Abstract Contact" exact="dermatitis" post="produces an inflammatory reaction primarily via stimulation of keratinocytes"/>
 <result pre="able to reduce its cytotoxicity. An in vivo experiment of" exact="irritant contact dermatitis" post="(ICD) in mice induced by TPA showed that NCEUG"/>
 <result pre="to reduce its cytotoxicity. An in vivo experiment of irritant" exact="contact dermatitis" post="(ICD) in mice induced by TPA showed that NCEUG"/>
 <result pre="reduce its cytotoxicity. An in vivo experiment of irritant contact" exact="dermatitis" post="(ICD) in mice induced by TPA showed that NCEUG"/>
 <result pre="de Apoio ao Desenvolvimento Científico e Tecnológico 1. Introduction Contact" exact="dermatitis" post="accounts for 70–90% of all occupational skin diseases and"/>
 <result pre="the allergic skin reaction resulting from exposure to irritants (irritant" exact="contact dermatitis" post="(ICD)) or to allergens (allergic contact dermatitis (ACD)) ["/>
 <result pre="allergic skin reaction resulting from exposure to irritants (irritant contact" exact="dermatitis" post="(ICD)) or to allergens (allergic contact dermatitis (ACD)) ["/>
 <result pre="to irritants (irritant contact dermatitis (ICD)) or to allergens (allergic" exact="contact dermatitis" post="(ACD)) [ 1]. Several alterations are observed in epidermal"/>
 <result pre="irritants (irritant contact dermatitis (ICD)) or to allergens (allergic contact" exact="dermatitis" post="(ACD)) [ 1]. Several alterations are observed in epidermal"/>
 <result pre="in recent decades regarding the understanding of the pathophysiology of" exact="contact dermatitis," post="the ideal pharmacotherapy of both irritating as allergic contact"/>
 <result pre="of contact dermatitis, the ideal pharmacotherapy of both irritating as" exact="allergic contact dermatitis" post="remains a research target [ 9]. Despite the existence"/>
 <result pre="contact dermatitis, the ideal pharmacotherapy of both irritating as allergic" exact="contact dermatitis" post="remains a research target [ 9]. Despite the existence"/>
 <result pre="dermatitis, the ideal pharmacotherapy of both irritating as allergic contact" exact="dermatitis" post="remains a research target [ 9]. Despite the existence"/>
 <result pre="contribute for the control of several inflammatory diseases such as" exact="dermatitis" post="[ 44]. The treatment of human neutrophils with EUG"/>
 <result pre="in several chronic inflammatory diseases [ 8, 49] such as" exact="dermatitis" post="[ 50– 52]. Thus, we investigated whether EUG had"/>
 <result pre="to tissue damage in many chronic inflammatory diseases, such as" exact="dermatitis" post="[ 6]. The results obtained with EUG in this"/>
 <result pre="EUG and isoeugenol cytotoxicity demonstrated that these molecules promote growth" exact="suppression" post="in keratinocytes (HaCaT) and that the effects may be"/>
 <result pre="drug release and improving the efficacy in the treatment of" exact="contact dermatitis." post="It was demonstrated that polymeric nanocapsules did not produce"/>
 <result pre="used for treatment of skin disorders, in a model of" exact="contact dermatitis" post="after topical administration in rats led to a better"/>
 <result pre="for treatment of skin disorders, in a model of contact" exact="dermatitis" post="after topical administration in rats led to a better"/>
 <result pre="of myeloperoxidase (MPO) in tissue of mice submitted to ear" exact="contact dermatitis" post="induction with TPA ( Figure 8) indicates that the"/>
 <result pre="myeloperoxidase (MPO) in tissue of mice submitted to ear contact" exact="dermatitis" post="induction with TPA ( Figure 8) indicates that the"/>
 <result pre="drug release and improving the efficacy in the treatment of" exact="contact dermatitis." post="It was demonstrated that polymeric nanocapsules did not produce"/>
 <result pre="58]. Also, it was reported that in a model of" exact="contact dermatitis" post="after topical administration in rat nanocapsules containing clobetasol propionate,"/>
 <result pre="Also, it was reported that in a model of contact" exact="dermatitis" post="after topical administration in rat nanocapsules containing clobetasol propionate,"/>
 <result pre="committed cells [ 60]. In addition, the acute assay of" exact="irritant contact dermatitis" post="induced by TPA in mice using EUG showed that"/>
 <result pre="cells [ 60]. In addition, the acute assay of irritant" exact="contact dermatitis" post="induced by TPA in mice using EUG showed that"/>
 <result pre="[ 60]. In addition, the acute assay of irritant contact" exact="dermatitis" post="induced by TPA in mice using EUG showed that"/>
 <result pre="their potential in the treatment of topic diseases, such as" exact="contact dermatitis." post="Acknowledgments This work was supported by Coordenação de Aperfeiçoamento"/>
 <result pre="Wahlberg J. E. Maibach H. I. The epidemiology of occupational" exact="contact dermatitis" post="Handbook of Occupational Dermatology 2000 Berlin, Heidelberg Springer 3"/>
 <result pre="J. E. Maibach H. I. The epidemiology of occupational contact" exact="dermatitis" post="Handbook of Occupational Dermatology 2000 Berlin, Heidelberg Springer 3"/>
 <result pre="Lepoittevin J. P. Histopathological and immunohistopathological features of irritant and" exact="allergic contact dermatitis" post="Contact Dermatitis 2011 Berlin, Heidelberg Springer 167 176 10.1007/978-3-642-03827-3_9"/>
 <result pre="J. P. Histopathological and immunohistopathological features of irritant and allergic" exact="contact dermatitis" post="Contact Dermatitis 2011 Berlin, Heidelberg Springer 167 176 10.1007/978-3-642-03827-3_9"/>
 <result pre="P. Histopathological and immunohistopathological features of irritant and allergic contact" exact="dermatitis" post="Contact Dermatitis 2011 Berlin, Heidelberg Springer 167 176 10.1007/978-3-642-03827-3_9"/>
 <result pre="176 10.1007/978-3-642-03827-3_9 3 Corsini E. Galli C. L. Cytokines and" exact="irritant contact dermatitis" post="Toxicology Letters 1998 102-103 277 282 10.1016/S0378-4274(98)00323-3 10022266 4"/>
 <result pre="10.1007/978-3-642-03827-3_9 3 Corsini E. Galli C. L. Cytokines and irritant" exact="contact dermatitis" post="Toxicology Letters 1998 102-103 277 282 10.1016/S0378-4274(98)00323-3 10022266 4"/>
 <result pre="3 Corsini E. Galli C. L. Cytokines and irritant contact" exact="dermatitis" post="Toxicology Letters 1998 102-103 277 282 10.1016/S0378-4274(98)00323-3 10022266 4"/>
 <result pre="an indication of the role of oxidative stress in acute" exact="irritant contact dermatitis" post="European Journal of Dermatology 1998 1 8 12 9649716"/>
 <result pre="indication of the role of oxidative stress in acute irritant" exact="contact dermatitis" post="European Journal of Dermatology 1998 1 8 12 9649716"/>
 <result pre="of the role of oxidative stress in acute irritant contact" exact="dermatitis" post="European Journal of Dermatology 1998 1 8 12 9649716"/>
 <result pre="9649716 5 Ji H. Li X. K. Oxidative stress in" exact="atopic dermatitis" post="Oxidative Medicine and Cellular Longevity 2016 2016 8 10.1155/2016/2721469"/>
 <result pre="5 Ji H. Li X. K. Oxidative stress in atopic" exact="dermatitis" post="Oxidative Medicine and Cellular Longevity 2016 2016 8 10.1155/2016/2721469"/>
 <result pre="Kullisaar T. Rehema A. Vihalemm T. Patients with allergic and" exact="irritant contact dermatitis" post="are characterized by striking change of iron and oxidized"/>
 <result pre="T. Rehema A. Vihalemm T. Patients with allergic and irritant" exact="contact dermatitis" post="are characterized by striking change of iron and oxidized"/>
 <result pre="Rehema A. Vihalemm T. Patients with allergic and irritant contact" exact="dermatitis" post="are characterized by striking change of iron and oxidized"/>
 <result pre="9 Cohen D. E. Heidary N. Treatment of irritant and" exact="allergic contact dermatitis" post="Dermatologic Therapy 2004 17 4 334 340 10.1111/j.1396-0296.2004.04031.x 15327479"/>
 <result pre="Cohen D. E. Heidary N. Treatment of irritant and allergic" exact="contact dermatitis" post="Dermatologic Therapy 2004 17 4 334 340 10.1111/j.1396-0296.2004.04031.x 15327479"/>
 <result pre="D. E. Heidary N. Treatment of irritant and allergic contact" exact="dermatitis" post="Dermatologic Therapy 2004 17 4 334 340 10.1111/j.1396-0296.2004.04031.x 15327479"/>
 <result pre="H. et al. Effect of Syzygium aromaticum extract on immediate" exact="hypersensitivity" post="in rats Journal of Ethnopharmacology 1998 60 2 125"/>
 <result pre="Z. Antiasthmatic effects of eugenol in a mouse model of" exact="allergic asthma" post="by regulation of vitamin D3 upregulated protein 1/NF- κB"/>
 <result pre="Antiasthmatic effects of eugenol in a mouse model of allergic" exact="asthma" post="by regulation of vitamin D3 upregulated protein 1/NF- κB"/>
 <result pre="10.1006/meth.1996.0064 8812712 49 Semenza G. L. Hypoxia-inducible factors: mediators of" exact="cancer" post="progression and targets for cancer therapy Trends in Pharmacological"/>
 <result pre="L. Hypoxia-inducible factors: mediators of cancer progression and targets for" exact="cancer" post="therapy Trends in Pharmacological Sciences 2012 33 4 207"/>
 <result pre="Beck R. C. R. Improved efficacy in the treatment of" exact="contact dermatitis" post="in rats by a dermatological nanomedicine containing clobetasol propionate"/>
 <result pre="R. C. R. Improved efficacy in the treatment of contact" exact="dermatitis" post="in rats by a dermatological nanomedicine containing clobetasol propionate"/>
</results>
